Agilon health/$AGL
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Agilon health
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.
Ticker
$AGL
Sector
Primary listing
NYSE
Employees
1,076
Headquarters
Website
Agilon health Metrics
BasicAdvanced
$460M
-
-$0.77
0.14
-
Price and volume
Market cap
$460M
Beta
0.14
52-week high
$6.08
52-week low
$0.71
Average daily volume
18M
Financial strength
Current ratio
1.163
Quick ratio
1.123
Long term debt to equity
1.572
Total debt to equity
10.117
Interest coverage (TTM)
-59.56%
Profitability
EBITDA (TTM)
-347.304
Gross margin (TTM)
-1.76%
Net profit margin (TTM)
-5.35%
Operating margin (TTM)
-6.34%
Effective tax rate (TTM)
-0.43%
Revenue per employee (TTM)
$5,480,000
Management effectiveness
Return on assets (TTM)
-12.07%
Return on equity (TTM)
-60.68%
Valuation
Price to revenue (TTM)
0.078
Price to book
1.12
Price to tangible book (TTM)
1.44
Price to free cash flow (TTM)
-4.978
Free cash flow yield (TTM)
-20.09%
Free cash flow per share (TTM)
-0.223
Growth
Revenue change (TTM)
11.76%
Earnings per share change (TTM)
3.36%
3-year revenue growth (CAGR)
38.01%
3-year earnings per share growth (CAGR)
39.71%
What the Analysts think about Agilon health
Analyst ratings (Buy, Hold, Sell) for Agilon health stock.
Bulls say / Bears say
Agilon Health closed Q2 2025 with $327 million in cash and marketable securities versus just $35 million in total debt, ensuring strong liquidity to support operations and strategic initiatives (BusinessWire)
The company’s value-based care model brought in 116,000 ACO REACH model beneficiaries, diversifying revenue beyond Medicare Advantage and supporting long-term growth prospects (BusinessWire)
An upgraded data and analytics platform is providing enhanced insight into risk adjustment factors, with management expecting this will enable more accurate forecasting and margin improvement in 2026 (BusinessWire)
Revenue fell 6% year-over-year to $1.39 billion in Q2 2025, missing analyst estimates, as market exits and lower risk adjustment payments weighed on revenue growth (BusinessWire)
Medical margin turned negative $53 million from a $106 million gain in Q2 2024, underscoring increased profitability pressures in its core Medicare Advantage business (BusinessWire)
CEO Steven Sell resigned and the company withdrew its full-year 2025 guidance, signaling management instability and raising execution risks amid heightened industry challenges (BusinessWire)
Data summarised monthly by Lightyear AI. Last updated on 5 Sept 2025.
Agilon health Financial Performance
Revenues and expenses
Agilon health Earnings Performance
Company profitability
Agilon health News
AllArticlesVideos
AGILON HEALTH INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of agilon health, inc. - AGL
Business Wire2 weeks ago
agilon health, inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – AGL
Business Wire1 month ago
AGL Investors Have Opportunity to Join agilon health, inc. Fraud Investigation with the Schall Law Firm
Business Wire1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Agilon health stock?
Agilon health (AGL) has a market cap of $460M as of September 16, 2025.
What is the P/E ratio for Agilon health stock?
The price to earnings (P/E) ratio for Agilon health (AGL) stock is 0 as of September 16, 2025.
Does Agilon health stock pay dividends?
No, Agilon health (AGL) stock does not pay dividends to its shareholders as of September 16, 2025.
When is the next Agilon health dividend payment date?
Agilon health (AGL) stock does not pay dividends to its shareholders.
What is the beta indicator for Agilon health?
Agilon health (AGL) has a beta rating of 0.14. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.